NCT02873117View on ClinicalTrials.gov

Evaluation of the Potential Association Between 5α-reductase Inhibitors Prescription and Occurrence of High Grade Prostate Cancers

CompletedOBSERVATIONAL
Enrollment

5,154

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Benign Prostate Hyperplasia
Interventions
OTHER

Prostate biopsy, prostatectomy or prostate resection

Collection of prostate examination

Trial Locations (1)

35033

CHU de Rennes, Rennes

All Listed Sponsors
lead

Rennes University Hospital

OTHER

NCT02873117 - Evaluation of the Potential Association Between 5α-reductase Inhibitors Prescription and Occurrence of High Grade Prostate Cancers | Biotech Hunter | Biotech Hunter